Frontiers in Pharmacology | Inflammation Pharmacology

Review

Published on 25 Jan 2023

Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview

in Inflammation Pharmacology

Yasmeen Saeed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1110008

2,901 views
3 citations

Mini Review

Published on 23 Jan 2023

Self-reactive IgE and anti-IgE therapy in autoimmune diseases

in Inflammation Pharmacology

Anna Olewicz-Gawlik
Arleta Kowala-Piaskowska

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112917

18,228 views
8 citations

Mini Review

Published on 20 Jan 2023

Cholesterol metabolism in the regulation of inflammatory responses

in Inflammation Pharmacology

Rebekka Bauer
Bernhard Brüne
Tobias Schmid

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121819

8,207 views
21 citations

Original Research

Published on 20 Jan 2023

Sal003 alleviated intervertebral disc degeneration by inhibiting apoptosis and extracellular matrix degradation through suppressing endoplasmic reticulum stress pathway in rats

in Inflammation Pharmacology

Yan Chen
Baixing Li
Yue Xu
Tangjun Zhou
Changqing Zhao
Jie Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095307

2,931 views
7 citations

Review

Published on 19 Jan 2023

Traditional Chinese medicine for treatment of sepsis and related multi-organ injury

in Inflammation Pharmacology

Yaqin Song
Weiji Lin
Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1003658

16,625 views
30 citations

Correction

Published on 18 Jan 2023

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1109002

1,724 views

Correction

Published on 18 Jan 2023

Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1108989

1,845 views
2 citations

Review

Published on 17 Jan 2023

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine

in Inflammation Pharmacology

Rui Tian
Lin Yuan
Yuan Huang
Rui Zhang
Hao Lyu
Shuai Xiao
Dong Guo
Declan William Ali
Marek Michalak
Xing-Zhen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053602

6,572 views
5 citations

Original Research

Published on 16 Jan 2023

Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease

in Inflammation Pharmacology

Kouzhu Zhu
Xiaoliang Ding
Zhiyao Chen
Qinhua Xi
Xueqin Pang
Weichang Chen
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096816

2,374 views
7 citations

Review

Published on 16 Jan 2023

Targeting type I interferons in systemic lupus erythematous

in Inflammation Pharmacology

Sebastian Bruera
Thandiwe Chavula
Riya Madan
Sandeep K. Agarwal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1046687

11,257 views
23 citations

Original Research

Published on 13 Jan 2023

Neutralization of excessive CCL28 improves wound healing in diabetic mice

in Inflammation Pharmacology

Zhenlong Chen
Jacob M. Haus
Luisa A. DiPietro
Timothy J. Koh
Richard D. Minshall

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1087924

4,128 views
6 citations

Original Research

Published on 13 Jan 2023

Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

in Inflammation Pharmacology

Xu Yan
Tianjiao Lin
Qingyun Zhu
Yushi Zhang
Zhimin Song
Xinting Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090261

4,174 views
20 citations

Review

Published on 13 Jan 2023

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases

in Inflammation Pharmacology

Xiaoli Zhang
Yiming Ma
Guoqing Lv
Hongying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095366

8,706 views
39 citations

Editorial

Published on 12 Jan 2023

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases

in Inflammation Pharmacology

Qiuwang Zhang
Shihai Yan
Dongdong Sun
Zhirong Geng
Peixiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1134918

1,585 views
1 citation

Editorial

Published on 11 Jan 2023

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases

in Inflammation Pharmacology

Mingyu Zhang
Ok Joo Sul
Junjiang Fu
Qianqian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1121165

1,718 views

Original Research

Published on 10 Jan 2023

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases

in Inflammation Pharmacology

Nasren Eiza
Ofra Kessler
Adi Sabag
Gera Neufeld
E. Yvonne Jones
Zahava Vadasz

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1085892

3,031 views
4 citations